Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Gamma Butyrolactone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101250171A details a chiral phosphine-catalyzed method for gamma-butyrolactones, offering high ee values and yield for pharmaceutical intermediate manufacturing.
Patent CN109553595A reveals mild chiral gamma-butyrolactone synthesis. Reduces cost and improves supply chain reliability for pharmaceutical intermediates.
Patent CN111233795B reveals organic catalytic method. High yield and stereoselectivity ensure reliable supply chain for antitumor drug manufacturing.
Patent CN111196791B reveals a novel Rh-catalyzed route to chiral gamma-butyrolactones with high enantioselectivity, offering cost-effective API intermediate solutions.
Patent CN111233795A details a novel organocatalytic route to chiral gamma-butyrolactones with high stereoselectivity, offering cost-effective API intermediate manufacturing solutions.